Prehospital and transport
Agitated or Violent Patient Algorithm
Safety, words first, medical causes, then sedation that is monitored
1 Is the scene safe?
- Do not enter or try to control a scene with violence or weapons (NASEMSO V3)
- Law enforcement should be involved whenever the patient threatens self, the public or responders (NAEMSP 2021)
- Gloves and PPE; keep an exit behind you
Weapons or active violence → step 2Safe to approach → step 3
2 Retreat and wait for law enforcement
- If you are in danger, retreat to a safe place and wait (NAEMSP 2021)
- If you cannot retreat and are attacked, you may defend yourself as local law permits (NAEMSP 2021)
- EMS must not give sedatives to help an arrest or custody (NAEMSP 2021)
3 Verbal de-escalation first
- De-escalation takes precedence over physical or chemical restraint whenever possible (NAEMSP 2021)
- One calm speaker; build rapport; reassure; involve family if they calm the patient (NASEMSO V3)
- Score agitation with RASS, AMSS or BARS and repeat it (NASEMSO V3; NAEMSP 2021)
Calming and cooperating → step 4Danger to self or others despite de-escalation → step 5
4 Look for a medical cause
- Hypoxia, hypoglycemia, stroke, seizure, head injury, delirium, alcohol or drug intoxication (NAEMSP 2021); also consider withdrawal
- Glucose, SpO₂, temperature, vital signs, signs of trauma; note drugs on scene (NASEMSO V3)
- High-flow oxygen by mask treats hypoxia in a patient too agitated for oximetry (NAEMSP 2021)
A medical cause found → step 6Cooperative: transport and keep talking → step 7Escalating danger → step 5
5 Sedation needed: how high is the risk?
- Delirium with agitated behavior can lead to hyperthermia, hyperkalemia, rhabdomyolysis and cardiac arrest; rapid sedation may prevent them (NAEMSP 2021)
- Use the term delirium with agitated behavior (NAEMSP, NASEMSO) or hyperactive delirium with severe agitation (ACEP); in October 2023 ACEP withdrew approval of its 2009 excited delirium paper and said the term should not be used
- Choose by condition, medications, allergies and protocol (NASEMSO V3)
Adult, high violence risk or delirium with agitation → step 8Adult, less severe or partly cooperative → step 9Child → step 10
6 Treat the cause
- Hypoglycemia: dextrose per protocol; hypoxia: oxygen and ventilation
- Hyperthermia over 40 °C: cool at once with standard care; ice water immersion at 1–5 °C (2a), at least 0.15 °C/min, stop at 38.6 °C (AHA 2025)
- Severe agitation from stimulants: sedation is recommended (AHA 2025, class 1)
- Agitation after naloxone is often withdrawal: support the airway, no more naloxone
7 Monitor and reassess continuously
- Airway, SpO₂ and capnography, cardiac monitor as soon as possible, frequent blood pressure, mental status (NASEMSO V3)
- Check circulation and capillary refill in every restrained limb, and repeat (NAEMSP 2021; NASEMSO V3)
- After antipsychotics: watch for dystonia (treat with diphenhydramine or a benzodiazepine) and arrhythmias, especially a long QT (NASEMSO V3)
- Ground transport; air is not advised (NASEMSO V3). Document behavior, the reason for restraint, drugs, doses and every reassessment
Breathing slows or SpO₂ or ETCO₂ worsens → step 11Hot, rigid or still struggling → step 6
8 Rapid sedation: high violence risk
- Ketamine 4 mg/kg IM (onset 3–5 min) or 2 mg/kg IV (onset about 1 min) (NASEMSO V3)
- Or droperidol 5–10 mg IM (onset about 20 min) or 2.5 mg IV (NASEMSO V3)
- Or midazolam 5 mg IM, IV or IN (NASEMSO V3, which does not mark it as a high-violence-risk option)
- A rapid-onset drug is preferred for delirium with agitation or serious self-injury risk (NAEMSP 2021)
Physical restraint still needed → step 12Sedated: monitor → step 7
9 Sedation: other options
- Midazolam 5 mg IV, IM or IN; lorazepam 2 mg IV or 4 mg IM; diazepam 5 mg IV or 10 mg IM (NASEMSO V3)
- Haloperidol 5 mg IV or 5–10 mg IM; ziprasidone 10 mg IM; olanzapine 10 mg IM, or 10 mg ODT if the patient will take it (NASEMSO V3)
- Diphenhydramine 25–50 mg IM, IV or PO (NASEMSO V3)
Physical restraint still needed → step 12Sedated: monitor → step 7Escalating despite this → step 8
10 Child: weight-based doses
- Midazolam 0.05–0.1 mg/kg IV, 0.1–0.15 mg/kg IM or 0.3 mg/kg IN, max 5 mg (NASEMSO V3)
- Ketamine 1 mg/kg IV or 3 mg/kg IM (NASEMSO V3)
- Ages 6–12: haloperidol 1–3 mg IM (max 0.15 mg/kg); droperidol not routinely recommended (NASEMSO V3)
- Diphenhydramine 1 mg/kg, max 25 mg (NASEMSO V3); document the weight in kg
Physical restraint still needed → step 12Sedated: monitor → step 7
11 Oversedation or hypoventilation
- Open the airway (jaw thrust), sit up or turn to the side, oxygen
- Ventilate with a bag-mask if breathing is inadequate: 1 breath every 6 seconds (AHA 2025 BLS)
- Loosen any restraint near the chest or neck; check for vomiting
- No pulse: CPR and ALS; tell the receiving hospital early
12 Physical restraint: least restrictive, never prone
- Soft devices that release without a key; secure all four limbs to the stretcher frame, one arm up and one down for the most combative (NASEMSO V3)
- Stretcher sitting up; nothing may restrict the chest wall (NASEMSO V3)
- Physically restrained patients should also be sedated (NASEMSO V3); prolonged restraint without sedation is harmful (AHA 2025, 3: Harm)
- EMS does not use handcuffs; a police device that must stay means an officer rides along, or it is swapped for an EMS device (NAEMSP 2021)
Drugs in this algorithm
More prehospital and transport algorithms
- Traumatic Cardiac Arrest
- Field Triage of Injured Patients
- Opioid Overdose
- Field Delivery and Newborn Care
For education and exam preparation only. Follow your institution’s protocols. Study aid with typical adult values; follow your institution's protocols and current AHA guidelines.